Related Experiment Video

Updated: Aug 18, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Optimizing hypertension and vascular health: focus on ethnicity

Domenic Sica1

  • 1Section of Clinical Pharmacology and Hypertension, Division of Nephrology, Virginia Commonwealth University, Richmond, Virginia, USA. dsica@hsc.vcu.edu

Clinical Cornerstone
|April 27, 2005
PubMed

Insights

Black individuals face higher hypertension risks due to multifactorial causes, including lifestyle. Aggressive management with combination therapies is key for blood pressure control and cardiorenal protection.

Area of Science:

  • Cardiology
  • Nephrology
  • Genetics
  • Public Health

Background:

  • Black individuals exhibit a disproportionately higher risk for hypertension and its severe complications, such as end-stage renal disease and congestive heart failure, compared to other ethnic groups.
  • The increased risk is multifactorial, with genetic predispositions potentially playing a role, but lifestyle factors, particularly high body mass index, appear to exert a greater influence.

Purpose of the Study:

  • To summarize the current understanding of hypertension risk factors and management strategies in Black individuals.
  • To highlight the effectiveness of various antihypertensive agents and therapeutic approaches in this population.

Main Methods:

  • Review of existing literature and clinical guidelines regarding hypertension in Black populations.
  • Analysis of the comparative efficacy of different antihypertensive drug classes, including renin-angiotensin system blockers and calcium channel blockers.

Main Results:

  • While genetic factors may contribute, lifestyle factors like high body mass index are significant contributors to hypertension risk in Black individuals.
  • Aggressive blood pressure management using combination therapies is recommended for optimal cardiorenal protection.
  • Calcium channel blockers demonstrate potent blood pressure-lowering effects, with novel strategies like chronotherapy enhancing their utility.

Conclusions:

  • Hypertension management in Black individuals requires aggressive, individualized treatment strategies, often involving combination therapies.
  • Further research is needed to clarify the role of renin-angiotensin system blockers in Black patients, given their underrepresentation in clinical trials.
  • Calcium channel blockers represent a cornerstone therapy for hypertension in Black individuals, offering significant benefits for blood pressure control and cardiorenal protection.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...